ArticleApplied biochemistry and biotechnology2026
Synthesis of 4-hydroxybenzoic Acid in Escherichia coli by a Modular co-culture System.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cooperativity in microbial biotechnology: synthetic consortia as emerging metabolic engineering strategy for sustainable bioproduction.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Advancements in metabolic engineering and synthetic biology have enabled microbial production of an extensive range of valuable chemicals. Traditionally, a single microbial strain is used in these processes. However, the integration of complex, multi-layered regulatory mechanisms within metabolic pathways imposes a significant metabolic burden on host cells. To address these challenges, modular co-culture strategies have garnered increasing attention. In this study, we constructed a modular co-culture system to produce 4-hydroxybenzoic acid (4-HBA), which has applications across diverse fields, including food, medicine, and cosmetics. The complete 4-HBA synthesis pathway was segmented into upstream and downstream modules at the shikimic acid node, with each module constructed in separate Escherichia coli strains. During modular co-culture of the upstream and downstream strains, the maximum production titer of 4-HBA reached 0.928 g/L when the initial inoculation ratio of upstream to downstream strains was 2:1. This study represents the first report of 4-HBA synthesis using glucose as the sole carbon source through modular co-culture technology, thereby expanding the application scope of this technology and providing a valuable reference for microbial production of 4-HBA.
Indexed as
Identifiers
41452415What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.